Sir, Pereira [1] described a systematic review that examined the importance of cholesterol in psychopathology. The methods section of the paper listed the search terms but not the search date and the search strategy; in fact, the review lacked most of the characteristics that make a systematic review Preferred Reporting Items for Systematic Reviews and Meta-analyses compliant. [2] The single most important limitation of the review is that the findings of the identified studies were merely listed in a table. There was no critical evaluation of the literature, synthesis of findings, or discussion of the findings. There was neither take-home message nor new learning from the review. As a side comment, the review examined only studies published from January 2010 onward with no justification provided for the cutoff date. This is important because, when evaluating a field, there should be a good reason for excluding a substantial body of evidence that is relevant to the field.
A quarter of a centur y ago, a meta-analysis of six primar y prevention randomized controlled trials (RCTs) suggested that lowering serum cholesterol levels was associated with an increased risk of mortality related to accidents, suicide, or violence; [3] a decade later, a meta-analysis of 19 RCTs showed that deaths due to these causes were not increased in patients treated with statins for either primary prevention or secondary prevention. [4] Subsequent studies were also reassuring. [5] In fact, meta-analysis of epidemiological as well as RCT data suggests that there is a lower risk of depression in statin users, and that statin augmentation of selective serotonin reuptake inhibitors has an antidepressant effect. [6, 7] Against this is the finding from a meta-analysis of epidemiological data that lower serum cholesterol levels are associated with a higher risk of suicide attempt and completion.
[8] We believe, as should all scientists, that RCT data comprise a superior quality of evidence and that the findings of the RCT meta-analyses [4, 7] should therefore receive more weightage than the findings of the epidemiological data meta-analysis. [8] Finally, and most important of all, it is important to reduce serum cholesterol in patients with major mental illness if only because such patients are at an increased risk of metabolic syndrome; statin treatment in such patients could, in the long run, significantly reduce medical morbidity and mortality, much as it does in the general population. The risk-benefit ratio clearly favors the reduction of serum cholesterol through statin treatment. [5, 9] Financial support and sponsorship Nil.
The "EMIC" and "ETIC" Models: Two Equally Important Insight Assessments in Psychosis
Sir, This letter is in response to the expert's viewpoint on explanatory models of insight in psychosis by Jacob. [1] This article is well written and highly informative because it promulgates the relevance of the sparsely used Explanatory Models (EM's) in the clinical settings.
I would like to suggest a few points as a reader in the article. First and foremost, the author tried to explain in the introduction of the article that insight explained in its [2] Culture Specific Explanations for Mental Illness (EMIC) and Universality of Mental Illness (ETIC) [2] perspectives in psychosis and the explanation by clinician and person affected with psychosis equally determines the levels of insight in the affected individual. When considering insight on this ground, the majority of the studies on EMs conducted among the population of India shows the importance given only to EMIC models. [2] [3] [4] Of course, it is also worth note by giving equal importance to the overlapping ETIC model of insight. Therefore, research asserts that personal and phenomenological aspects also incorporated along with psychiatric evaluation. [5] The assessments of the EMIC model along with ETIC only helpful to reduce the distance between the treating clinician and the person with psychosis.
Second, in the article author trying only to connect insight with delusional ideas while the author missed connecting symptom of hallucinations, which are false perceptual experiences and a valid determining factor for insight in person with psychosis. In cases with hallucinations, insight was found hampered. [6] Third, it is agreeable that the instruments widely used to assess insight made to fetch biomedical [4] models and symptoms. The author rightly pointed about the EMIC. [7] However, there are few more instruments to tap EMs in psychosis: 1. Explanatory Models Association Task (EMAT) [8] 2. Barts Explanatory Model Inventory, self-report checklist [2, 9] 3. McGill Illness Narrative Interview [5, 7] 4. Short Explanatory Model Interview (SEMI) tool can utilize in the psychiatry settings along with the existing instruments of ETIC.
Developing the quantitative instruments for EMs is practically not easy because phenomenological individual explanatory beliefs are different from other's beliefs and should be distinguished from general beliefs about illnesses hence that, it is not generalizable. However, if researchers can identify culturally rooted common themes of EMs (spiritual/ mystical factors, psychosocial factors, and biological factors [8] after identifying the common EMs makes it possible for the researchers to develop new instruments. [2] Another possibility is to refine the existing instruments (EMIC, EMAT, SEMI, and Indiana Psychiatric Illness Inventory [IPII]). [5] The first focus should be to validate the instruments (EM's EMIC) to be culture specific so that it will help the clinician to understand individuals EMIC perspectives.
[8] EMIC and the ETIC models of illnesses are also equally important where one will be supporting the other strand for assessment and
